Moderately to Severely Active Crohns Disease | Clinical Trial Radar | Chugai Pharmaceutical

Powered by Trial Radar

Advanced

Trial Radar AI Trial Candidate or Patient Patient Caregiver Healthcare Pro Biotech Pro Biotech Investor Researcher Other
	Let's discuss and explore clinical trials with Chugai Pharmaceutical as a lead sponsor or collaborator. Showing clinical trials for Moderately to Severely Active Crohns Disease. I can help you find nearby clinical trials and understand health conditions and treatments.

Search by location, facility...

Search by keywords...

Study Title	Status
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-2) NCT06819891	Recruiting
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) NCT06819878	Recruiting